Fabien Zoulim Selected Research

Fabien Zoulim Research Topics

Disease

125	Infections 06/2022 - 01/2002
106	Chronic Hepatitis B 11/2022 - 01/2002
49	Hepatitis B 11/2022 - 01/2002
48	Fibrosis (Cirrhosis) 06/2022 - 08/2005
29	Hepatocellular Carcinoma (Hepatoma) 06/2022 - 08/2005
22	Liver Diseases (Liver Disease) 01/2022 - 01/2002
19	Chronic Hepatitis C 06/2022 - 09/2004
12	Hepatitis C 01/2022 - 03/2003
12	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 11/2004
12	Neoplasms (Cancer) 05/2021 - 06/2013
12	Hepatitis 01/2021 - 10/2004
10	Coinfection 01/2021 - 03/2014
10	Viremia 01/2018 - 02/2002
8	Disease Progression 01/2022 - 01/2002
8	Chronic Hepatitis (Chronic Active Hepatitis) 01/2022 - 03/2003
7	Virus Diseases (Viral Diseases) 01/2018 - 09/2003
6	Persistent Infection 01/2021 - 06/2004
5	Liver Neoplasms (Liver Cancer) 08/2021 - 10/2016
5	HIV Infections (HIV Infection) 01/2017 - 02/2006
4	Inflammation (Inflammations) 11/2022 - 10/2009
3	Hypertension (High Blood Pressure) 01/2021 - 01/2018
3	Carcinogenesis 12/2017 - 03/2016
2	Esophageal and Gastric Varices (Esophageal Varices) 06/2022 - 01/2019
2	Hypercholesterolemia 06/2022 - 07/2009
2	Portal Hypertension 01/2022 - 03/2011
2	Hemorrhage 01/2022 - 01/2021
2	Asthenia 10/2020 - 01/2013
2	Mitochondrial Diseases (Mitochondrial Disease) 03/2016 - 10/2014
2	Insulin Resistance 03/2016 - 10/2014
2	Diarrhea 04/2007 - 06/2002

Drug/Important Bio-Agent (IBA)

79	Antiviral Agents (Antivirals)IBA 11/2022 - 02/2002
40	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022 - 08/2004
30	Hepatitis B e AntigensIBA 11/2022 - 06/2003
28	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 02/2002
26	InterferonsIBA 03/2022 - 01/2002
23	Ribavirin (Virazole)FDA LinkGeneric 10/2020 - 06/2002
19	NucleosidesIBA 12/2020 - 09/2002
18	Lamivudine (Epivir)FDA Link 01/2017 - 01/2002
17	AntigensIBA 11/2022 - 09/2007
16	Tenofovir (Viread)FDA Link 01/2022 - 07/2009
15	entecavir FDA Link 01/2022 - 05/2006
14	Pharmaceutical PreparationsIBA 01/2022 - 01/2002
13	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2006
12	Circular DNAIBA 01/2022 - 02/2002
12	VaccinesIBA 01/2021 - 01/2003
11	RNA (Ribonucleic Acid)IBA 11/2022 - 08/2005
11	Interferon-alpha (Interferon Alfa)IBA 01/2020 - 03/2003
9	NucleotidesIBA 10/2020 - 10/2004
9	Surface Antigens (Surface Antigen)IBA 01/2019 - 08/2004
9	adefovir dipivoxil (Hepsera)FDA Link 10/2010 - 06/2004
8	Alanine Transaminase (SGPT)IBA 01/2019 - 10/2004
7	Protease Inhibitors (Protease Inhibitor)IBA 04/2019 - 12/2011
7	adefovirIBA 03/2017 - 02/2002
7	telaprevirIBA 12/2015 - 11/2012
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2005
6	AntibodiesIBA 01/2021 - 01/2010
5	BilirubinIBA 06/2022 - 01/2018
5	Immunoglobulins (Immunoglobulin)IBA 05/2022 - 10/2006
5	Viral DNAIBA 01/2022 - 12/2007
5	CytokinesIBA 12/2019 - 01/2009
5	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 12/2015 - 11/2012
5	RacivirIBA 10/2013 - 09/2002
4	Netrin-1IBA 11/2022 - 03/2016
4	Peptides (Polypeptides)IBA 01/2022 - 01/2012
4	nasIBA 01/2020 - 07/2007
4	Biological ProductsIBA 04/2019 - 06/2012
4	SimeprevirIBA 04/2019 - 01/2015
4	LipidsIBA 03/2016 - 02/2009
4	Emtricitabine (Emtriva)FDA Link 04/2014 - 06/2003
3	hepatitis B hyperimmune globulinIBA 05/2022 - 10/2006
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 08/2021 - 01/2021
3	daclatasvirIBA 10/2020 - 11/2016
3	SofosbuvirIBA 10/2020 - 11/2016
3	EnzymesIBA 01/2019 - 01/2017
2	AlbuminsIBA 06/2022 - 01/2022
2	Coffee FDA Link 01/2022 - 01/2019
2	ChromatinIBA 01/2022 - 01/2017
2	Immunologic Factors (Immunomodulators)IBA 01/2021 - 09/2003
2	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 01/2021 - 09/2003
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021 - 01/2009
2	Viral RNAIBA 01/2020 - 12/2015
2	pgRNAIBA 01/2020 - 01/2019
2	Transaminases (Aminotransferases)IBA 01/2019 - 01/2018
2	peginterferon alfa-2a (Pegasys)FDA Link 01/2017 - 01/2015
2	Messenger RNA (mRNA)IBA 10/2016 - 01/2011
2	LigandsIBA 03/2016 - 01/2011
2	EpitopesIBA 04/2015 - 11/2010
2	faldaprevirIBA 01/2013 - 12/2011
2	deleobuvirIBA 01/2013 - 12/2011
2	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2012 - 08/2010
2	DNA VaccinesIBA 03/2012 - 01/2003
2	hepatitis B virus X proteinIBA 11/2011 - 07/2011
2	Glycoside Hydrolase InhibitorsIBA 04/2007 - 04/2006

Therapy/Procedure

103	Therapeutics 11/2022 - 01/2002
18	Liver Transplantation 05/2022 - 01/2002
5	Aftercare (After-Treatment) 06/2022 - 08/2010
3	Transplantation 01/2021 - 01/2018
2	Investigational Therapies (Experimental Therapy) 01/2020 - 11/2019
2	Retreatment 01/2020 - 01/2018
2	Duration of Therapy 01/2019 - 01/2015